Be Aware of How Ajovy Stacks Up to Other CGRP Antagonists

November 2020

You'll see Ajovy (fremanezumab), a new biologic to PREVENT migraine in adults.

It limits vasodilation by blocking calcitonin gene-related peptide (CGRP)...similar to Aimovig (erenumab) and Emgality (galcanezumab).

These "CGRP antagonists" are once-monthly, self-administered subcutaneous injections...or Ajovy can be given as 3 consecutive injections on the same day once every 3 months.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Fever Improve Accuracy of Noncontact Infrared Thermometers
Allergic Reactions Watch for Differences With Emerade and Other Epinephrine Auto-Injectors
Substance Use Disorder Stay Alert for Unexpected Culprits of Rx and OTC Med Misuse
Supplements Clear Up Confusion About "Memory Supplements"
Migraine Be Aware of How Ajovy Stacks Up to Other CGRP Antagonists
Med Administration Know When to Give Patients a "Green Light" to Cut or Crush Meds
Practice Evaluate if Guidelines "Fit" Your Patients
HIV & AIDS Get Ready for the Once-Monthly Injectable HIV Med, Cabenuva
Depression Stay Alert for Depression During and After Pregnancy
Infectious Diseases Answer Questions About Using Steroids for COVID-19

Be Aware of How Ajovy Stacks Up to Other CGRP Antagonists

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents